CTMX - Wall Street Estimates - CytomX Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 0.6772

0.296 %

$ 53 M

Market Cap

4.23

P/E

Price Target Average

545.30%

Revenue Forecast Estimate

--15.48%

EBIT Estimate

--94.37%

Net Income Estimate

--325.76%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets CytomX Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for CTMX of $4.37 , with forecasts ranging from a low of $2.5 to a high of $8 .

CTMX Lowest Price Target Wall Street Target

2.5 USD 269.17%

CTMX Average Price Target Wall Street Target

4.37 USD 545.30%

CTMX Highest Price Target Wall Street Target

8 USD 1081.33%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free